Livzon Pharmaceutical Group Statistics

Total Valuation

Livzon Pharmaceutical Group has a market cap or net worth of CNY 29.88 billion. The enterprise value is 23.95 billion.

Market Cap	29.88B
Enterprise Value	23.95B

Important Dates

The next estimated earnings date is Thursday, March 27, 2025.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	Jul 8, 2024

Share Statistics

Livzon Pharmaceutical Group has 906.93 million shares outstanding. The number of shares has decreased by -0.74% in one year.

Current Share Class	n/a
Shares Outstanding	906.93M
Shares Change (YoY)	-0.74%
Shares Change (QoQ)	+1.60%
Owned by Insiders (%)	0.40%
Owned by Institutions (%)	15.31%
Float	474.79M

Valuation Ratios

The trailing PE ratio is 16.86 and the forward PE ratio is 15.38.

PE Ratio	16.86
Forward PE	15.38
PS Ratio	2.88
PB Ratio	2.39
P/TBV Ratio	2.19
P/FCF Ratio	12.52
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.21, with an EV/FCF ratio of 8.96.

EV / Earnings	11.83
EV / Sales	2.02
EV / EBITDA	7.21
EV / EBIT	10.18
EV / FCF	8.96

Financial Position

The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.27.

Current Ratio	1.84
Quick Ratio	1.58
Debt / Equity	0.27
Debt / EBITDA	1.23
Debt / FCF	1.53
Interest Coverage	24.59

Financial Efficiency

Return on equity (ROE) is 15.09% and return on invested capital (ROIC) is 7.84%.

Return on Equity (ROE)	15.09%
Return on Assets (ROA)	5.91%
Return on Capital (ROIC)	7.84%
Revenue Per Employee	1.33M
Profits Per Employee	226,669
Employee Count	8,933
Asset Turnover	0.48
Inventory Turnover	2.13

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.02% in the last 52 weeks. The beta is 0.27, so Livzon Pharmaceutical Group's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	+8.02%
50-Day Moving Average	37.62
200-Day Moving Average	37.67
Relative Strength Index (RSI)	41.50
Average Volume (20 Days)	6,378,644

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Livzon Pharmaceutical Group had revenue of CNY 11.86 billion and earned 2.02 billion in profits. Earnings per share was 2.19.

Revenue	11.86B
Gross Profit	7.46B
Operating Income	2.35B
Pretax Income	2.72B
Net Income	2.02B
EBITDA	3.30B
EBIT	2.35B
Earnings Per Share (EPS)	2.19

Full Income Statement

Balance Sheet

The company has 10.81 billion in cash and 4.10 billion in debt, giving a net cash position of 6.71 billion or 7.40 per share.

Cash & Cash Equivalents	10.81B
Total Debt	4.10B
Net Cash	6.71B
Net Cash Per Share	7.40
Equity (Book Value)	14.94B
Book Value Per Share	15.44
Working Capital	7.60B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.34 billion and capital expenditures -671.04 million, giving a free cash flow of 2.67 billion.

Operating Cash Flow	3.34B
Capital Expenditures	-671.04M
Free Cash Flow	2.67B
FCF Per Share	2.95

Full Cash Flow Statement

Margins

Gross margin is 62.94%, with operating and profit margins of 19.84% and 17.08%.

Gross Margin	62.94%
Operating Margin	19.84%
Pretax Margin	22.90%
Profit Margin	17.08%
EBITDA Margin	27.83%
EBIT Margin	19.84%
FCF Margin	22.55%

Dividends & Yields

This stock pays an annual dividend of 1.35, which amounts to a dividend yield of 3.66%.

Dividend Per Share	1.35
Dividend Yield	3.66%
Dividend Growth (YoY)	-15.63%
Years of Dividend Growth	n/a
Payout Ratio	67.66%
Buyback Yield	0.74%
Shareholder Yield	4.40%
Earnings Yield	5.93%
FCF Yield	7.99%

Dividend Details

Stock Splits

The last stock split was on July 3, 2019. It was a forward split with a ratio of 1.3.

Last Split Date	Jul 3, 2019
Split Type	Forward
Split Ratio	1.3

Scores

Livzon Pharmaceutical Group has an Altman Z-Score of 3.62.

Altman Z-Score	3.62
Piotroski F-Score	n/a